Figure 1From: Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients Distribution (in %) of blood culture isolates. [Group 1 heparin; 2003ā2005 30 BSI; group 2 TauroLockā¢; 2005ā2007; 25 BSI).Back to article page